OOIR: Observatory of International Research

Papers

(The H4-Index of Cellular & Molecular Biology Letters is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Correction: Laboratory methods to decipher epigenetic signatures: a comparative review	132
Identification of COX4I2 as a hypoxia-associated gene acting through FGF1 to promote EMT and angiogenesis in CRC	130
Targeting microRNAs with thymoquinone: a new approach for cancer therapy	127
Insight into the physiological and pathological roles of the aryl hydrocarbon receptor pathway in glucose homeostasis, insulin resistance, and diabetes development	117
Targeting UBR5 in hepatocellular carcinoma cells and precise treatment via echinacoside nanodelivery	109
Recent insights into the microRNA-dependent modulation of gliomas from pathogenesis to diagnosis and treatment	106
Downregulation of exosomal miR-7-5p promotes breast cancer migration and invasion by targeting RYK and participating in the atypical WNT signalling pathway	103
The current landscape of microRNAs (miRNAs) in bacterial pneumonia: opportunities and challenges	101
Therapeutic utility of mesenchymal stromal cell (MSC)-based approaches in chronic neurodegeneration: a glimpse into underlying mechanisms, current status, and prospects	93
Slc25a5 regulates adipogenesis by modulating ERK signaling in OP9 cells	90
ALKBH5 promotes lung fibroblast activation and silica-induced pulmonary fibrosis through miR-320a-3p and FOXM1	85
Raman spectroscopy biochemical characterisation of bladder cancer cisplatin resistance regulated by FDFT1: a review	84
Exosomal lncRNA TUG1 from cancer-associated fibroblasts promotes liver cancer cell migration, invasion, and glycolysis by regulating the miR-524-5p/SIX1 axis	81
Molecular mechanism of lncRNA SNHG12 in immune escape of non-small cell lung cancer through the HuR/PD-L1/USP8 axis	77
Osteoporosis pathogenesis and treatment: existing and emerging avenues	70
Mitochondrial potassium channels: A novel calcitriol target	68
lncRNA PVT1: a novel oncogene in multiple cancers	64
Integrated analysis of tRNA-derived small RNAs in proliferative human aortic smooth muscle cells	62
The interaction of canonical Wnt/β-catenin signaling with protein lysine acetylation	57
Melatonin and cancer suppression: insights into its effects on DNA methylation	56
5-Methoxyflavone-induced AMPKα activation inhibits NF-κB and P38 MAPK signaling to attenuate influenza A virus-mediated inflammation and lung injury in vitro and in vivo	54
tRF-3013b inhibits gallbladder cancer proliferation by targeting TPRG1L	50
COVID-19 therapies: do we see substantial progress?	48
Reversely immortalized mouse salivary gland cells presented a promising metabolic and fibrotic response upon BMP9/Gdf2 stimulation	47
Acquired drug resistance interferes with the susceptibility of prostate cancer cells to metabolic stress	47

Targeting uridine–cytidine kinase 2 induced cell cycle arrest through dual mechanism and could improve the immune response of hepatocellular carcinoma	46
Esterase D stabilizes FKBP25 to suppress mTORC1	46
METTL16 promotes hepatocellular carcinoma progression through downregulating RAB11B-AS1 in an m6A-dependent manner	45
Down-regulation of EVA1A by miR-103a-3p promotes hepatocellular carcinoma cells proliferation and migration	45
Diversification of PAR signaling through receptor crosstalk	44
Identifying pathways regulating the oncogenic p53 family member ΔNp63 provides therapeutic avenues for squamous cell carcinoma	44
SNHG3 could promote prostate cancer progression through reducing methionine dependence of PCa cells	43
Absent in melanoma 2 (AIM2) in rheumatoid arthritis: novel molecular insights and implications	42
LAGE3 promoted cell proliferation, migration, and invasion and inhibited cell apoptosis of hepatocellular carcinoma by facilitating the JNK and ERK signaling pathway	41
RNF7 inhibits apoptosis and sunitinib sensitivity and promotes glycolysis in renal cell carcinoma via the SOCS1/JAK/STAT3 feedback loop	40